Solu

Highlights ⭐

• Solving the problem: Antibiotic resistance is a major concern worldwide, and it has seen some acceleration in recent years. According to studies, antibiotic resistance directly caused over one million deaths worldwide in 2019, and nearly five million people died from bacterial infections that are resistant to antibiotics. Solu is building an extensive pathogen DNA library in order to prevent antibiotic resistance via "better research and faster identification." 🔗
• It's fast: Solu is the fastest way to perform 90% of routine workflows for bacteria, helping researchers get their next paper out faster.
• Bold goal: Solu's technology has potential to avoid unnecessary deaths from resistant infections. With better understanding of pathogens, faster diagnostics, and robust surveillance, Solu paves the way for developing new therapies, such as antibiotics, bacteriophages and antitoxin agents.
• Collaborating with top universities: Solu has started collaborating with top international universities, including Stanford University and the University of Hamburg, which use Solu's product in their research on antibiotic resistance.